A Clinical Study to Determine Whether an Investigational Medication (SEP-363856) Changes How Long it Takes for Food to Move Through the Stomach Into the Small Intestine in Patients With Schizophrenia. The Study Will Help to Understand Any Effect SEP-363856 May Have on Blood Sugar Levels After a Meal
Condition:   Schizophrenia Interventions:   Drug: SEP-363856;   Drug: Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole) Sponsor:   Sunovion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2022 Category: Research Source Type: clinical trials

Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents
Condition:   Chemotherapy-induced Nausea and Vomiting Interventions:   Drug: Ondansetron;   Drug: Dexamethasone;   Drug: Aprepitant;   Drug: Olanzapine Sponsor:   Federal Research Institute of Pediatric Hematology, Oncology and Immunology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials